Black Book Recaps 2025 Research Announcements and Client‑Rated Honors; Reaffirms Vendor‑Agnostic, Independently Validated Intelligence and 2026 Commitments 
Psyence BioMed’s Strategic Collaboration with PsyLabs Yields Breakthrough in High-Purity Ibogaine Production
NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) is pleased...
InflaRx to Report Second Quarter 2025 Results on August 7, 2025
JENA, Germany, July 31, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting...
Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization
WALTHAM, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership,...
FOXO TECHNOLOGIES INC. ANNOUNCES LICENSE RENEWAL AND PROVIDES OPERATIONAL UPDATE FOR MYRTLE RECOVERY CENTERS, INC.
WEST PALM BEACH, FLORIDA, July 31, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies, Inc., (NYSE American: FOXO) (“FOXO” or the “Company”) today...
Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results
Received U.S. FDA approval for EMPAVELI® (pegcetacoplan) for treatment of patients 12 years and older with C3G and primary IC-MPGNAnnounced capped...
Pasithea Therapeutics Completes Enrollment and Initial Dosing of First Cohort from its Phase 1/1b Clinical Trial of PAS-004 in Adult NF1 Patients
– Initial interim safety, tolerability, biomarker, and preliminary efficacy data expected in Q1 2026 –MIAMI, July 31, 2025 (GLOBE NEWSWIRE)...
BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Chief Executive Officer Upon his Retirement in December
RESEARCH TRIANGLE PARK, N.C., July 31, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that its president and...
Relmada Therapeutics to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025
CORAL GABLES, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage...
INmune Bio Inc. to Report Second Quarter 2025 Financial Results and Provide Corporate Update on Thursday, August 7th
Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, July 31, 2025...
Amicus Therapeutics Announces Second Quarter 2025 Financial Results and Corporate Updates
Q2 2025 Total Revenue of $154.7M, up 18% at CER Galafold® Q2 Revenue of $128.9M, up 12% at CER Pombiliti®...
Atea Pharmaceuticals to Host Second Quarter 2025 Financial Results and Business Update Conference Call on August 7, 2025
BOSTON, July 31, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged...
Mobile-health Network Solutions Introduces AI Checker, Proprietary System That Critiques Quality of Doctors’ Telehealth Notes
'Major Step' in the Development of AI DoctorSingapore, Singapore--(Newsfile Corp. - July 31, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR)...
Unbuzzd Wellness Commences Reg D Capital Raise Campaign
Investment Opens for up to US$5.0 Million through a Regulation D 506(c) Offering to Fund Growth and Path to Possible...
SO TECHAFRICA and Mindhyve.ai™ Forge Strategic Alliance to Advance Agentic AI for National Development in Nigeria
ABUJA, Nigeria and NEWPORT BEACH, Calif., July 30, 2025 /PRNewswire/ -- In a landmark collaboration aimed at accelerating innovation, capacity...
Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone
SOUTHAMPTON, England, July 30, 2025 /PRNewswire/ -- MODERNISED (NIHR207538), a multi-site UK clinical study has passed a key milestone: over 450...
Waystar Reports Second Quarter 2025 Results
Q2 revenue growth of 15% year-over-year Q2 net income of $32.2 million and non-GAAP net income of $65.7 million Q2...
Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference
BURLINGTON, Mass., July 30, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the...
GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference
MENLO PARK, Calif., July 30, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect...
Health Gorilla Joins CMS-Aligned Network as a Trusted Data Network Enabling AI-Ready Clinical Data Exchange
CORAL GABLES, Fla., July 30, 2025 /PRNewswire/ -- Health Gorilla, a designated Qualified Health Information Network (QHIN) under the Trusted Exchange...
BARDA awards nearly $10 million to RIVANNA to accelerate development of CADe/x AI module for Accuro XV
CHARLOTTESVILLE, Va., July 30, 2025 /PRNewswire/ -- RIVANNA®, developers of imaging-based medical technologies, announced that it received $9.92 million in...